PR Newswire – Start of Day

Globe NewswirePhase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19...

Page 38 of 39 1 37 38 39

Other Newzz